.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Covington
Harvard Business School
Boehringer Ingelheim
Novartis
Fish and Richardson
Daiichi Sankyo
Cipla
Queensland Health
Express Scripts

Generated: July 22, 2017

DrugPatentWatch Database Preview

PENTAM Drug Profile

« Back to Dashboard

What is the patent landscape for Pentam, and when can generic versions of Pentam launch?

Pentam is a drug marketed by Fresenius Kabi Usa, Watson Labs, Baxter Hlthcare, and Hospira. and is included in four NDAs.

The generic ingredient in PENTAM is pentamidine isethionate. There are thirteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.

Summary for Tradename: PENTAM

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list1
Bulk Api Vendors: see list112
Clinical Trials: see list1
Patent Applications: see list784
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PENTAM at DailyMed

Pharmacology for Tradename: PENTAM

Drug ClassAntiprotozoal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
PENTAM
pentamidine isethionate
INJECTABLE;INJECTION019264-001Oct 16, 1984RXYesYes► Subscribe► Subscribe
Hospira
PENTAMIDINE ISETHIONATE
pentamidine isethionate
INJECTABLE;INJECTION073479-001Jun 30, 1992DISCNNoNo► Subscribe► Subscribe
Watson Labs
PENTAMIDINE ISETHIONATE
pentamidine isethionate
INJECTABLE;INJECTION074303-001Aug 17, 1995DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare
PENTAMIDINE ISETHIONATE
pentamidine isethionate
INJECTABLE;INJECTION073617-001Dec 18, 1995DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Johnson and Johnson
Healthtrust
McKesson
Moodys
Deloitte
Express Scripts
Fish and Richardson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot